Valuation: GC Genome Corporation

Market Cap 18TCr 14Cr 12Cr 11Cr 10Cr 19Cr 1.26TCr 20Cr 139.02Cr 55Cr 688.36Cr 51Cr 50Cr 2.16TCr P/E 2026 *
-
P/E 2027 * -
Enterprise Value 12Cr 91.82T 83.63T 77.06T 70.1T 1L 85.03L 1L 9L 4L 46.44L 3L 3L 1.46Cr EV / Sales 2026 *
3.16x
EV / Sales 2027 * 2.33x
Free-Float
49.55%
Yield 2026 *
-
Yield 2027 * -
1 day-5.97%
1 week-8.10%
Current month-15.16%
1 month-17.43%
3 months+35.68%
6 months+11.24%
Current year+13.20%
1 week 7,500
Extreme 7500.00000000
8,680
1 month 6,000
Extreme 6000
10,310
Current year 4,100
Extreme 4100
10,480
1 year 4,100
Extreme 4100
10,480
3 years 4,100
Extreme 4100
15,180
5 years 4,100
Extreme 4100
15,180
10 years 4,100
Extreme 4100
15,180
Manager TitleAgeSince
Chief Executive Officer 57 26/03/2020
Director of Finance/CFO 50 27/03/2025
Comptroller/Controller/Auditor 45 29/03/2024
Director TitleAgeSince
Director/Board Member 57 30/03/2023
Date Insider Type Main position Quantity % Market Cap. Importance
17/06/25 Free

Chief Executive Officer

1,69,285 -
17/06/25 Free 1,38,250 --
Change 5-day change 1-year change 3-year change Capi.($)
-5.97%-8.10%+21.38% - 15Cr
+1.00%-9.52%+6.31%+18.43% 10TCr
+3.31%-4.70%-0.15%+91.45% 9.62TCr
-5.70%-14.32%+21.21%+399.00% 4.2TCr
-4.76%+0.13%+14.29%+95.31% 3.2TCr
-0.47%-0.90%+40.41%+73.91% 3TCr
-0.31%-0.51%+37.67%+91.53% 2.85TCr
-0.15%-7.99%+40.98%+305.22% 2.1TCr
-0.62%-2.67%-16.84%-20.10% 1.94TCr
0.00%+0.77%-4.24%+32.77% 1.7TCr
Average -1.37%-4.26%+16.10%+120.84% 4TCr
Weighted average by Cap. -0.03%-6.58%+12.17%+107.87%

Financials

2026 *2027 *
Net sales 3.9TCr 2.91Cr 2.65Cr 2.44Cr 2.22Cr 4.16Cr 269.2Cr 4.38Cr 30Cr 12Cr 147.03Cr 11Cr 11Cr 461.45Cr 4.88TCr 3.64Cr 3.31Cr 3.05Cr 2.78Cr 5.21Cr 336.84Cr 5.48Cr 37Cr 15Cr 183.98Cr 14Cr 13Cr 577.41Cr
Net income - -
Net Debt -5.94TCr -4.43Cr -4.03Cr -3.72Cr -3.38Cr -6.34Cr -410.01Cr -6.66Cr -45Cr -18Cr -223.94Cr -17Cr -16Cr -702.83Cr -6.88TCr -5.13Cr -4.67Cr -4.3Cr -3.92Cr -7.34Cr -474.89Cr -7.72Cr -52Cr -21Cr -259.38Cr -19Cr -19Cr -814.05Cr
Projected Income Statement - Annual - GC Genome Corporation
Logo GC Genome Corporation
GC Genome Corp is a Korea-based company principally engaged in the provision of genome testing and analysis services. The Company is principally engaged in the provision of prenatal and newborn screening genetic testing services, cancer patient precision diagnosis genetic testing services, precision diagnosis genetic testing service for patients with rare diseases, health checkup test services as well as others.
Employees
-
Date Price Change Volume
20/26/20 ₩7,720.00 -5.97% 2,24,970
19/26/19 ₩8,210.00 +2.62% 1,67,032
18/26/18 ₩8,000.00 +4.99% 2,92,976
17/26/17 ₩7,620.00 -3.67% 2,14,400
16/26/16 ₩7,910.00 -7.49% 2,40,816

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - GC Genome Corporation
  1. Stock Market
  2. Stocks
  3. A340450 Stock